Tocqueville Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-7,327
| Closed | -$620K | – | 787 |
|
|
2018
Q4 | $620K | Buy |
7,327
+309
| +4% | +$26.1K | 0.01% | 525 |
|
|
2018
Q3 | $1.2M | Sell |
7,018
-3,996
| -36% | -$684K | 0.02% | 474 |
|
|
2018
Q2 | $1.42M | Buy |
11,014
+370
| +3% | +$47.8K | 0.02% | 461 |
|
|
2018
Q1 | $1.1M | Sell |
10,644
-2,526
| -19% | -$260K | 0.01% | 500 |
|
|
2017
Q4 | $1.13M | Sell |
13,170
-31,339
| -70% | -$2.68M | 0.01% | 497 |
|
|
2017
Q3 | $3.78M | Buy |
44,509
+1,042
| +2% | +$88.5K | 0.04% | 362 |
|
|
2017
Q2 | $3.29M | Hold |
43,467
| – | – | 0.04% | 356 |
|
|
2017
Q1 | $2.87M | Buy |
43,467
+11,061
| +34% | +$730K | 0.04% | 376 |
|
|
2016
Q4 | $2.05M | Buy |
32,406
+9,275
| +40% | +$588K | 0.03% | 409 |
|
|
2016
Q3 | $1.47M | Buy |
23,131
+1,290
| +6% | +$82.1K | 0.02% | 451 |
|
|
2016
Q2 | $1.63M | Sell |
21,841
-2,260
| -9% | -$168K | 0.02% | 448 |
|
|
2016
Q1 | $1.61M | Buy |
24,101
+3,102
| +15% | +$207K | 0.02% | 426 |
|
|
2015
Q4 | $1.42M | Buy |
20,999
+8,175
| +64% | +$553K | 0.02% | 476 |
|
|
2015
Q3 | $685K | Hold |
12,824
| – | – | 0.01% | 629 |
|
|
2015
Q2 | $807K | Sell |
12,824
-19,236
| -60% | -$1.21M | 0.01% | 612 |
|
|
2015
Q1 | $1.54M | Buy |
32,060
+8,015
| +33% | +$386K | 0.02% | 515 |
|
|
2014
Q4 | $798K | Buy |
24,045
+8,015
| +50% | +$266K | 0.01% | 620 |
|
|
2014
Q3 | $470K | Hold |
16,030
| – | – | 0.01% | 633 |
|
|
2014
Q2 | $623K | Buy |
16,030
+801
| +5% | +$31.1K | 0.01% | 667 |
|
|
2014
Q1 | $639K | Sell |
15,229
-801
| -5% | -$33.6K | 0.01% | 530 |
|
|
2013
Q4 | $526K | Buy |
16,030
+1,603
| +11% | +$52.6K | 0.01% | 570 |
|
|
2013
Q3 | $390K | Sell |
14,427
-9,618
| -40% | -$260K | ﹤0.01% | 704 |
|
|
2013
Q2 | $561K | Buy |
+24,045
| New | +$561K | 0.01% | 610 |
|